Silexion Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2013	FY 2012
Period Ending	Apr '25 Apr 21, 2025	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Quick Ratio	3.64	3.64	10.47
Current Ratio	3.85	3.85	10.64
Return on Equity (ROE)	-116.66%	-116.66%	-
Return on Assets (ROA)	-62.13%	-62.13%	-
Return on Capital (ROIC)	-73.07%	-73.07%	-
Buyback Yield / Dilution	-	-16.10%	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q